[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2131043T3 - Preparaciones a base de cinc atomizadas. - Google Patents

Preparaciones a base de cinc atomizadas.

Info

Publication number
ES2131043T3
ES2131043T3 ES90308015T ES90308015T ES2131043T3 ES 2131043 T3 ES2131043 T3 ES 2131043T3 ES 90308015 T ES90308015 T ES 90308015T ES 90308015 T ES90308015 T ES 90308015T ES 2131043 T3 ES2131043 T3 ES 2131043T3
Authority
ES
Spain
Prior art keywords
zinc
atomized
preparations based
ophthalmological
fever
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308015T
Other languages
English (en)
Inventor
Derek Bryce-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2131043T3 publication Critical patent/ES2131043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

EL PRESENTE INVENTO PROVEE UN TRATAMIENTO SIMPLE, BARATO Y EFICAZ PARA UNA CONDICION ALERGICA, ESPECIALMENTE PARA LA FIEBRE DEL HENO O EL ASMA, Y COMPRENDE UN SPRAY NASAL, ORAL UN OFTALMOLOGICO, CONTENIENDO UNA SOLUCION DIHIDRA DE ION DE ZINC, ESPECIALMENTE SULFATO Y/O CLORURO DE ZINC
ES90308015T 1989-07-20 1990-07-20 Preparaciones a base de cinc atomizadas. Expired - Lifetime ES2131043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916625A GB8916625D0 (en) 1989-07-20 1989-07-20 Respiratory tract spray preparations

Publications (1)

Publication Number Publication Date
ES2131043T3 true ES2131043T3 (es) 1999-07-16

Family

ID=10660351

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90308015T Expired - Lifetime ES2131043T3 (es) 1989-07-20 1990-07-20 Preparaciones a base de cinc atomizadas.

Country Status (14)

Country Link
US (1) US5688532A (es)
EP (1) EP0409662B1 (es)
JP (1) JP3033992B2 (es)
AT (1) ATE180165T1 (es)
AU (1) AU628609B2 (es)
CA (1) CA2021534C (es)
DE (1) DE69033112T2 (es)
DK (1) DK0409662T3 (es)
ES (1) ES2131043T3 (es)
GB (1) GB8916625D0 (es)
IE (1) IE902638A1 (es)
MY (1) MY106730A (es)
NZ (1) NZ234591A (es)
ZA (1) ZA905716B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8902300D0 (en) * 1989-02-02 1989-03-22 Bryce Smith Derek Antirhinoviral preparations
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
US6344210B2 (en) * 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
US6083525A (en) * 1996-05-10 2000-07-04 Fust; Charles A. Compositions for freshening nostrils and sinus cavities
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
US6759062B2 (en) * 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US20040058015A1 (en) * 2000-06-01 2004-03-25 Yuanjin Tao Compositions and methods for treating eye discomfort and eye disease
US20030215491A1 (en) * 2001-04-30 2003-11-20 Hensley Charles B. Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
WO2003006030A1 (en) 2001-07-11 2003-01-23 Smith C Steven Novel composition and method for altering allergenic protein in the environment
US7985425B1 (en) * 2001-12-07 2011-07-26 Smith Jack V Non-pharmacological method for treating depression, skin disorders and improving overall health and wellness
NL1020832C2 (nl) * 2002-06-12 2003-12-15 P K Benelux B V Farmaceutische samenstelling voor nasale toediening met een zinkverbinding, en toepassing.
WO2004011017A1 (en) * 2002-07-31 2004-02-05 Himalayan International Institute Of Yoga Science And Philosophy Nasal irrigation solutions and methods of using same
US20040180006A1 (en) * 2003-03-12 2004-09-16 Sceusa Nicholas A. Methods and compositions for blocking the calcium cascade
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
DE102006011012A1 (de) * 2006-03-09 2007-09-13 Gundula Geske Verwendung von Zinkcysteinat zur Behandlung von Entzündungen oder Allergien der Atemwege
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
US8337906B2 (en) * 2006-07-25 2012-12-25 Zinreich James Nasal composition
US20080026078A1 (en) * 2006-07-25 2008-01-31 Zinreich James Nasal composition
JP2008133222A (ja) * 2006-11-28 2008-06-12 Institute Of Physical & Chemical Research 亜鉛イオンによる転写因子ｓｔａｔの活性制御
IN2014CN03950A (es) * 2011-11-01 2015-10-16 Rohto Pharma
KR102094182B1 (ko) * 2018-06-28 2020-03-30 주식회사 알랙스탠드 아연 함유 수용성 폴리글루타믹산 복합체 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
CA1291034C (en) * 1987-10-19 1991-10-22 Mostafa S. Fahim Composition for promoting epithelial regeneration
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
DE3443985A1 (de) * 1984-12-01 1986-06-05 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Arzneimittelzubereitungen gegen mykotische und bakterielle infektionen mit einem gehalt an wirkstoffen, welche zink in ionisierter form freisetzen
DE3629107A1 (de) * 1986-08-27 1988-03-03 Cassella Ag Verwendung von zinkgluconat und dieses enthaltende medizinische zubereitungen zur behandlung von asthmatischen zustaenden
GB8902300D0 (en) * 1989-02-02 1989-03-22 Bryce Smith Derek Antirhinoviral preparations

Also Published As

Publication number Publication date
AU628609B2 (en) 1992-09-17
JPH03135919A (ja) 1991-06-10
CA2021534C (en) 1995-12-26
DE69033112D1 (de) 1999-06-24
CA2021534A1 (en) 1991-01-21
MY106730A (en) 1995-07-31
JP3033992B2 (ja) 2000-04-17
AU5971190A (en) 1991-01-24
DK0409662T3 (da) 1999-11-08
DE69033112T2 (de) 1999-10-21
NZ234591A (en) 1992-11-25
EP0409662A3 (en) 1992-02-05
EP0409662A2 (en) 1991-01-23
EP0409662B1 (en) 1999-05-19
GB8916625D0 (en) 1989-09-06
ZA905716B (en) 1991-07-31
ATE180165T1 (de) 1999-06-15
IE902638A1 (en) 1991-02-27
US5688532A (en) 1997-11-18

Similar Documents

Publication Publication Date Title
ES2131043T3 (es) Preparaciones a base de cinc atomizadas.
NZ232356A (en) Device for nasal administration of unchelated ionic zinc
AU8081987A (en) Small particle aerosol liposome and liposome-drug combinations for medical use
RU95101387A (ru) Концентрированный водный раствор аргатробана
ATE250926T1 (de) Beclomethazon-nanopartikel dispersionen enthaltende aerosole
EP0326196A3 (en) Aqueous pharmaceutical preparation
BG105391A (en) Storable concentrate of formoterol active substance
FI950909A (fi) Rasvahappojohdannaisia
TR23919A (tr) Atomize edici meme ve kullanimi.
DE59000518D1 (de) Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen.
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
DE3682862D1 (de) Aerosolmittel zur nasenverstaeubung von vitamin b 12.
GB9410817D0 (en) Medicaments
AU584333B2 (en) Method of medical treatment of human viral diseases utilizing 1-```-d-ribofuranosyl-1,2,4-triazole-3- carboxamide
FR2674434B1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
AU5992786A (en) Increasing aqueous humor outflow
Grigson Behind the mask
CA2088588A1 (en) Treatment of hair loss and dermatological problems
RU95108659A (ru) Препарат, стимулирующий иммуногенез - стимбон-2
IT1173385B (it) Procedimento per spruzzare vigneti e frutteti,e spruzzatore per l'esecuzione del procedimento
RU97116821A (ru) Способ лечения респираторных заболеваний

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 409662

Country of ref document: ES